Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01802008 · ClinicalTrials.gov registry record · NA

Comparison of Adenoma Detection Miss Rates at Colonoscopy Associated With Different Withdrawal Times

A NA study of Adenoma and Adenoma and/or Adenocarcinoma, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
200
Enrollment target
2
Study locations

NCT01802008: Completed NA study of Adenoma and Adenoma and/or Adenocarcinoma, sponsored by Stanford University.

NCT01802008 is a NA study of Adenoma and Adenoma and/or Adenocarcinoma that has completed, run by Stanford University. The registered enrollment target is 200 participants, below the 679-participant average among 6 other Adenoma trials with a reported enrollment target (71% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01802008, a NA study of Adenoma and Adenoma and/or Adenocarcinoma, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target
2
Study locations

Study Summary

The objective of this study is to determine the optimal withdrawal time for colonoscopy. A 6-minute withdrawal time is currently the standard of care but has only been evaluated in an observational fashion. The investigators believe that this should be validated in a standardized fashion. If the benefits of a 6 minute withdrawal are proven in this study (ie a low polyp/adenoma miss rate and a high polyp/adenoma detection rate), then this will support widespread adoption of a 6 minute withdrawal as the standard of care. This in turn may decrease the occurence of 'interval colon cancers', which are early colon cancers arising in subjects despite their having undergone colonoscopy. Our hypothesis is that the polyp/adenoma detection rate will be unacceptably low and the polyp/adenoma miss rate will be unacceptably high in the 3-minute withdrawal group when compared to the 6-minute withdrawal group.

Primary Outcome

Polyp/adenoma detection rate will be calculated for each segment of the tandem colonoscopy- this will be calculated as the number of polyps/adenomas that are discovered and resected for each segment of the tandem colonoscopy.

Interventions

  • PROCEDURE 3-minute withdrawal time
  • PROCEDURE 6-minute withdrawal time

Study Locations (2)

California

  • Veterans Administration Hospital (Palo Alto) - Palo Alto
  • Stanford University - Palo Alto

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2012-09
Est. Completion 2013-08
Phase NA
Stanford University

1,744 total trials

What the finished NCT01802008 record still lists

NCT01802008 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 679-participant average among 6 other Adenoma trials with a reported enrollment target (71% lower).

The record links to 2 conditions, with Adenoma appearing as the primary indexed condition, and to 2 interventions - of which 3-minute withdrawal time is the first listed.

NCT01802008 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01802008 about?

NCT01802008 is a clinical study titled "Comparison of Adenoma Detection Miss Rates at Colonoscopy Associated With Different Withdrawal Times". The objective of this study is to determine the optimal withdrawal time for colonoscopy. A 6-minute withdrawal time is currently the standard of care but has only been evaluated in an observational fashion. The investigators believe that this should be validated in a standardized fashion. If the ben...

What is the current status of trial NCT01802008?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2012-09. Estimated completion is 2013-08.

What conditions does trial NCT01802008 study?

This clinical trial studies the following conditions: Adenoma, Adenoma and/or Adenocarcinoma.

What interventions are being tested in trial NCT01802008?

The interventions under investigation include: 3-minute withdrawal time (PROCEDURE), 6-minute withdrawal time (PROCEDURE).

Who is sponsoring clinical trial NCT01802008?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01802008 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Adenoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01802008, the US trial registry maintained by the National Library of Medicine. NCT01802008 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.